Summit Therapeutics Inc. today reported its financial results for the second quarter and six months ended June 30, 2026 and provided an update on clinical and operational progress. "The clinical ...
Tech Times on MSN
First photonic time crystal halves terahertz losses: gold metamaterial opens route to new lasers
Photonic time crystal research achieved a world first on July 29, 2026: scientists from École Polytechnique, Collège de ...
Hobby comrades, if there is one thing I am very passionate about, it’s coffee. I have often dreamt about quitting my 9-5 and ...
LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose ...
Minor cuts and scrapes usually heal in time, but losing a finger or a whole limb? For most vertebrates, that's a done deal.
Any minor cut or scrape sets the body's natural healing process in motion. However, deep wounds are far more vulnerable to ...
This guide brings together practical recommendations and workflow considerations to reduce unnecessary troubleshooting and ...
Astellas Pharma India today announced that VYLOY (zolbetuximab) in combination with chemotherapy is now available for the ...
Key Points Interested in NeoGenomics, Inc.? Here are five stocks we like better. NeoGenomics raised its 2026 outlook after Q2 ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results